• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对日本原子弹幸存者癌症发病率剂量反应中的曲率程度与体外测量的染色体畸变中的曲率程度进行比较。

A comparison of the degree of curvature in the cancer incidence dose-response in Japanese atomic bomb survivors with that in chromosome aberrations measured in vitro.

作者信息

Little M P

机构信息

Department of Epidemiology and Public Health, Imperial College School of Medicine, St Mary's Campus, London, UK.

出版信息

Int J Radiat Biol. 2000 Oct;76(10):1365-75. doi: 10.1080/09553000050151646.

DOI:10.1080/09553000050151646
PMID:11057745
Abstract

PURPOSES

To compare the degree of curvature in the dose-response for chromosome aberrations and for radiation-induced cancer.

MATERIALS AND METHODS

Comparison of the ratio of the quadratic and linear coefficients (in dose) in Japanese atomic bomb survivor cancer incidence data, based on follow-up to 1987 and taking account of random errors in DS86 dose estimates with the same ratio in four datasets of chromosome aberrations in peripheral blood lymphocytes measured in vitro and exposed to 60Co gamma radiation.

RESULTS

There are no statistically significant differences between the four in vitro datasets in the ratio of the quadratic to the linear coefficients for dicentrics or chromosome translocations, nor are there indications of differences between this ratio for dicentrics and that for complete chromosome translocations (p > 0.1 in all cases). If the 0-4 Gy dose range is used in the Japanese atomic bomb survivor data, the ratio of the quadratic to the linear coefficients for all solid cancers is 0.06 -1 (95% CI -0.22, 0.67) and so is not significantly different from 0; this ratio is statistically highly inconsistent (p<0.0001) with the analogous ratio estimated for the in vitro chromosome aberration data (4.20 Sv-1; 95% CI 3.06, 6.51). By contrast, there are no statistically significant differences (p=0.42) between the ratio of the quadratic to the linear coefficients for leukaemia incidence in the Japanese cohort, 1.81 Sv-1 (95% CI 0.21, > 1,000), with that for chromosome aberrations in vitro. These results are not markedly changed if the 0-2 Gy dose range is used in the Japanese atomic bomb survivor data.

CONCLUSIONS

It is unlikely that in vitro chromosome aberrations could be a correlate for the initiating radiogenic lesions leading to radiation-induced solid cancers. However, taken together with certain other biological information, it may not be unreasonable on this basis to use in vitro chromosome aberrations in peripheral blood lymphocytes as a correlate of the radiogenic lesions leading to radiation-induced leukaemia.

摘要

目的

比较染色体畸变和辐射诱发癌症的剂量反应曲线的曲率程度。

材料与方法

基于对日本原子弹爆炸幸存者至1987年的随访数据,比较二次项系数与线性系数之比(剂量方面),同时考虑DS86剂量估计中的随机误差,并将其与体外测量的外周血淋巴细胞经60Coγ射线照射后的四个染色体畸变数据集中的相同比例进行比较。

结果

四个体外数据集在双着丝粒或染色体易位的二次项系数与线性系数之比上无统计学显著差异,双着丝粒的该比例与完全染色体易位的该比例之间也无差异迹象(所有情况p>0.1)。如果在日本原子弹爆炸幸存者数据中使用0 - 4 Gy剂量范围,所有实体癌的二次项系数与线性系数之比为0.06 - 1(95%可信区间 - 0.22, 0.67),与0无显著差异;该比例与体外染色体畸变数据估计的类似比例(4.20 Sv-1;95%可信区间3.06, 6.51)在统计学上高度不一致(p<0.0001)。相比之下,日本队列中白血病发病率的二次项系数与线性系数之比为1.81 Sv-1(95%可信区间0.21, >1,000),与体外染色体畸变的该比例无统计学显著差异(p = 0.42)。如果在日本原子弹爆炸幸存者数据中使用0 - 2 Gy剂量范围,这些结果无明显变化。

结论

体外染色体畸变不太可能作为导致辐射诱发实体癌的初始辐射损伤的相关指标。然而,结合某些其他生物学信息,基于此将外周血淋巴细胞中的体外染色体畸变用作导致辐射诱发白血病的辐射损伤的相关指标可能并非不合理。

相似文献

1
A comparison of the degree of curvature in the cancer incidence dose-response in Japanese atomic bomb survivors with that in chromosome aberrations measured in vitro.对日本原子弹幸存者癌症发病率剂量反应中的曲率程度与体外测量的染色体畸变中的曲率程度进行比较。
Int J Radiat Biol. 2000 Oct;76(10):1365-75. doi: 10.1080/09553000050151646.
2
Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.从日本原子弹幸存者癌症发病率剂量反应的曲率分析中推导低剂量外推因子。
Int J Radiat Biol. 2000 Jul;76(7):939-53. doi: 10.1080/09553000050050954.
3
Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold.日本原子弹幸存者癌症死亡率剂量反应中的曲率:缺乏阈值证据。
Int J Radiat Biol. 1998 Oct;74(4):471-80. doi: 10.1080/095530098141348.
4
Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.日本原子弹幸存者癌症发病率剂量反应曲线的证据。
Int J Radiat Biol. 1996 Jul;70(1):83-94. doi: 10.1080/095530096145364.
5
Cancer and non-cancer effects in Japanese atomic bomb survivors.日本原子弹幸存者中的癌症及非癌症影响。
J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19.
6
Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.良性和恶性疾病放射治疗后癌症发病率和死亡率风险与日本原子弹幸存者中观察到的癌症风险的比较。
Int J Radiat Biol. 2001 Apr;77(4):431-64. doi: 10.1080/09553000010022634.
7
Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.日本原子弹幸存者癌症剂量反应曲线中的曲线性。
Environ Health Perspect. 1997 Dec;105 Suppl 6(Suppl 6):1505-9. doi: 10.1289/ehp.97105s61505.
8
Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation.原子弹爆炸幸存者的稳定染色体畸变:25年调查结果
Radiat Res. 2001 Oct;156(4):337-46. doi: 10.1667/0033-7587(2001)156[0337:scaiab]2.0.co;2.
9
Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.针对日本原子弹幸存者数据的灵活剂量反应模型:癌症风险的贝叶斯估计与预测。
Radiat Environ Biophys. 2004 Dec;43(4):233-45. doi: 10.1007/s00411-004-0258-3. Epub 2004 Nov 25.
10
Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.原子弹幸存者剂量测定法近期变化对癌症死亡率风险估计的影响。
Radiat Res. 2004 Oct;162(4):377-89. doi: 10.1667/rr3232.

引用本文的文献

1
Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.放疗中散射线和次级射线致第二恶性肿瘤风险评估。
Health Phys. 2012 Nov;103(5):652-61. doi: 10.1097/HP.0b013e318261113d.
2
Low-LET-induced radioprotective mechanisms within a stochastic two-stage cancer model.低 LET 诱导的随机两阶段癌症模型中的放射防护机制。
Dose Response. 2006 May 22;3(4):508-18. doi: 10.2203/dose-response.003.04.006.
3
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
关于外照射放疗诱发二次癌症的剂量学研究综述。
Phys Med Biol. 2008 Jul 7;53(13):R193-241. doi: 10.1088/0031-9155/53/13/R01. Epub 2008 Jun 9.